Acura Pharma (ACUR) Misses Q2 EPS by 3c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- S&P 500 notches record-high close as rate-hike worries ease
- Oil settles down 2% on weak demand outlook, hefty US crude build
- BofA lifts server CPU TAM to $210bn+ on the rise of AI agents
- Burry doubles down on Nebius short after stock surges 34% on earnings
- JPMorgan gets bullish on Salesforce, says concerns are "overblown"
Acura Pharmaceuticals Announces Second Quarter 2015 Financial Results
August 3, 2015 4:15 PM EDTPALATINE, IL -- (Marketwired) -- 08/03/15 --
Acura Pharmaceuticals, Inc. (NASDAQ: ACUR), a specialty pharmaceutical company developing products intended to address medication abuse and misuse, announced today financial results for the three and six months ended June 30, 2015.
The Company reported a net loss of $2.7 million for the second quarter 2015 or $0.05 per diluted share, compared to net loss of $3.5 million or $0.07 per diluted share for the same period in 2014. Revenues for the quarter were $0.3 million compared to $35 thousand in the second quarter of 2014.
Research and development expenses associated with... More
